Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

IDO1/2-IN-1

IDO1/2-IN-1 (compound 4t) is the first potent IDO1/IDO2 dual inhibitor with IC50s of 28 nM and 144 nM for IDO1 and IDO2, respectively. IDO1/2-IN-1 exhibits antitumor activies. Orally active[1].

Product Specifications

CAS Number

[2310286-45-2]

UNSPSC

12352005

Target

Indoleamine 2,3-Dioxygenase (IDO)

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ido1-2-in-1.html

Concentration

10mM

Purity

98.06

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

FC1=CC=C(C=C1Br)/N=C(C2=NON=C2NCCN3N=NC(COCCO)=C3)/NO

Molecular Formula

C16H18BrFN8O4

Molecular Weight

485.27

References & Citations

[1]He X, et al. Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy. J Med Chem. 2021;64 (24) :17950-17968.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

IDO1; IDO2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

FLASK RB 1 CN 19/26 & 2 ASN 19/26 I/C JT
4383B24 4 Units

FLASK RB 1 CN 19/26 & 2 ASN 19/26 I/C JT

Ask
View Details
Rabbit Polyclonal SUCLA2 Antibody
NBP2-97755-100ul 100 µL

Rabbit Polyclonal SUCLA2 Antibody

Ask
View Details
Tbata (NM_001017409) Mouse Tagged ORF Clone Lentiviral Particle
MR224608L3V 200 µL

Tbata (NM_001017409) Mouse Tagged ORF Clone Lentiviral Particle

Ask
View Details
Inhibin alpha (INHA) Human siRNA Oligo Duplex (Locus ID 3623)
SR302420 1 Kit

Inhibin alpha (INHA) Human siRNA Oligo Duplex (Locus ID 3623)

Ask
View Details
Human SEC14L1 (NM_001144001) AAV Particle
RC226558A1V 250 µL

Human SEC14L1 (NM_001144001) AAV Particle

Ask
View Details